Invida to market Ipsen drugs in Southeast Asia
This article was originally published in Scrip
Executive Summary
Invida is to exclusively distribute and promote Ipsen's Diphereline 3.75mg and 11.25mg (triptorelin), Somatuline Autogel (lanreotide), and Increlex (IGF-1) drugs in selected countries in Southeast Asia.